GFAP and Alzheimer disease: In regard to serum samples, the Chicago Health and Aging Project, a population‐based prospective study of Canadian residents,15 and the Amsterdam Dementia Cohort, a clinic‐based prospective study,16 reported a significant association between higher serum GFAP levels and the risk of developing AD and all‐cause dementia, respectively.